Zobrazeno 91 - 100
of 23 504
pro vyhledávání: ''
Autor:
Haldun Oğuz, Muhammed KÜrŞad Yelken, Kayhan ÖztÜrk, Hakan Coskun, Ozan BaĞiŞ ÖzgÜrsoy, Emel Çadalli Tatar, Zahide Çiler Büyükatalay, Ahmet Hakan Bİrkent, Elad Azİzlİ, Sevtap Akbulut, Necati Enver
Publikováno v:
Turkish Journal of Medical Sciences
Background/aim: This study aimed to assess the inflammatory adverse reactions of vocal fold injection laryngoplasty with hyaluronic acid. Materials and methods: This study was a retrospective chart review of patients who underwent vocal fold injectio
Autor:
Naoyuki Uchida, Masahiro Abe, Shuichi Taniguchi, Hideki Araoka, Hideyuki Maruyama, Yoshihito Otsuka, Muneyoshi Kimura, Sho Ogura, Tomohisa Watari, Shinsuke Takagi
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 40:2095-2104
The aim of this study was to clarify the clinical and microbiological characteristics of Corynebacterium bacteremia in hematological patients. We retrospectively reviewed the medical records of patients with Corynebacterium bacteremia from April 2013
Publikováno v:
International Journal of Gynecologic Cancer. 31:824-828
ObjectiveIn this study we investigated response rates of bevacizumab in addition to weekly paclitaxel and carboplatin in neoadjuvant setting in cervical cancer stage IB–IIB.MethodsIn this retrospective study we included patients with FIGO 2018 stag
Autor:
Yannick Schreiber, Caroline Fischer, Katja Schmitz, Dominique Thomas, Lisa Hahnefeld, Gerd Geisslinger, Sabine Wicker, Katrin Watschinger, Annett Wilken-Schmitz, Robert Gurke, Irmgard Tegeder, Ernst R. Werner, Sandra Trautmann, Robert Brunkhorst
Publikováno v:
Neurotherapeutics
Depletion of the enzyme cofactor, tetrahydrobiopterin (BH4), in T-cells was shown to prevent their proliferation upon receptor stimulation in models of allergic inflammation in mice, suggesting that BH4 drives autoimmunity. Hence, the clinically avai
Autor:
George Ansstas, Anastasia Ivanova, Elizabeth Claire Dees, Karen P. McKinnon, Nancy Garrett-Mead, Christy Arrowood, S. Percy Ivy, Gino K. In, Lokesh Agrawal, Zeynep Eroglu, Frances A. Collichio, Peng Wang, Glenn Liu, Stergios J. Moschos, Hsing-Hui Wang, Kathleen Conway, Craig C. Carson, Nancy E. Thomas, Nana Nikolaishvilli-Feinberg, Nikhil I. Khushalani, David W. Ollila, Kari Kendra, Sharon N. Edmiston, Paul B. Googe, James L. Abbruzzese, Jonathan S. Serody
Publikováno v:
Melanoma Res
Background IL-2 inducible kinase (ITK) is highly expressed in metastatic melanomas and its inhibition suppresses melanoma cell proliferation. We hypothesize that ibrutinib has a direct antitumor effect in melanoma cell lines and that treatment of met
Autor:
Bruce A. Littlefield, Elodie Modave, Amy Weaver, Bram Boeckx, Diether Lambrechts, Agnieszka Wozniak, Patrick Schöffski
Publikováno v:
Clinical Cancer Research. 27:3106-3115
Purpose:A randomized phase III study evaluated the efficacy of eribulin versus dacarbazine in patients with advanced liposarcoma and leiomyosarcoma. Improved overall survival (OS) led to approval of eribulin for liposarcoma, but not for leiomyosarcom
Autor:
Orly Sapir, Amir Gal-Oz, Yoav Granot, Aviram Hochstadt, Eihab Ghantous, Ariel Borohovitz, Lior Lupu, Yishay Szekely, Ilan Merdler, Yaron Arbel, Nadav Furie, Merav Ingbir, Shmuel Banai, Philippe Taieb, Yael Lichter, Ariel Banai, Yan Topilsky
Publikováno v:
Internal and Emergency Medicine
Coronavirus 2019 disease (COVID-19) continues to challenge healthcare systems globally as many countries are currently experiencing an increase in the morbidity and mortality. Compare baseline characteristics, clinical presentation, treatments, and c
Publikováno v:
Mayo Clinic Proceedings. 96:1033-1040
Breast cancer remains the most common cancer in women in the United States. For certain women at high risk for breast cancer, endocrine therapy (ET) can greatly decrease the risk. Tools such as the Breast Cancer Risk Assessment Tool (or Gail Model) a
Autor:
Vasantha Lakshmi Gali, Mingzhi Zhang, Xiaosheng Fang, Yong Li, Fredrick B. Hagemeister, Donna M. Weber, Sheeba K. Thomas, Hans C. Lee, Zijun Y. Xu-Monette, Dahlia Sano, Manman Deng, Robert Z. Orlowski, Ken H. Young, Feng Zhu, Yingjun Wang
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 4, Pp 361-374 (2021)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
Waldenström macroglobulinemia (WM) is a distinct type of indolent lymphoplasmacytic lymphoma (LPL) with a high frequency of MYD88L265P mutation. Treatment for WM/LPL is highly variable in clinic and ibrutinib (a Bruton tyrosine kinase inhibitor, BTK
Publikováno v:
Rheumatology. 61:223-229
Objective The objective of this study was to compare the prophylactic effect of regular-dose (RD, 1.2 mg/day) vs low-dose (LD, 0.6 mg/day) colchicine on gout flare when initiating urate-lowering therapy. Methods In this retrospective cohort study, we